The Geographic Frontier: Analyzing Territorial Expansion and Production Hubs in the Global Antibody Ecosystem
The Shift Toward Regional Bio-Manufacturing For decades, the production of high-end biologics was concentrated in a few hubs in the US and Europe. However, we are now seeing a "Regionalization" of the antibody industry. Governments in Asia and the Middle East are investing billions to build "Bio-Parks" that can produce monoclonal antibodies locally. This shift is driven by the desire for...
0 Comments 0 Shares 20 Views 0 Reviews
MTSocial https://mtsocial.ir